Harbin Pharmaceutical Group Co

Harbin Pharmaceutical Group Co EPS

The Earnings per Share (EPS) of Harbin Pharmaceutical Group Co (600664.SS) as of Oct 19, 2026 is 0.14 CNY. In the previous year, Earnings per Share (EPS) was 0.24 CNY — a change of -40.90% (lower).

EPS

0.14CNY

YoY

-40.90%

Last updated:

Earnings per Share (EPS) of Harbin Pharmaceutical Group Co is 2025 0.14 CNY. Earnings per Share (EPS) of Harbin Pharmaceutical Group Co was 2024 0.24 CNY. It decreases by -40.90% lower compared to the previous year.

The Harbin Pharmaceutical Group Co EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
0.15 CNY
Jan 1, 2022
0.18 CNY
Jan 1, 2023
0.16 CNY
Jan 1, 2024
0.24 CNY
Jan 1, 2025
0.14 CNY
Jan 1, 2026 (e)
0.24 CNY
Jan 1, 2027 (e)
0.28 CNY
Jan 1, 2028 (e)
0.32 CNY
The Harbin Pharmaceutical Group Co EPS history
YEAREPSYoY
est0.32CNY+14.29%
est0.28CNY+16.67%
est0.24CNY+67.16%
0.14CNY-40.90%
0.24CNY+54.79%
0.16CNY-11.81%
0.18CNY+20.43%
0.15CNY-136.56%
-0.40CNY-1,655.38%
0.03CNY-80.94%
0.14CNY-16.46%
0.16CNY-48.40%
0.32CNY+36.29%
0.23CNY+137.09%
0.10CNY+44.68%
0.07CNY-66.26%
0.20CNY-27.29%
0.28CNY-48.78%
0.54CNY+21.14%
0.44CNY+10.66%
0.40CNY+47.22%
0.27CNY+20.32%
0.23CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Harbin Pharmaceutical Group Co Stock analysis

What does Harbin Pharmaceutical Group Co do? Harbin Pharmaceutical Group Co Ltd is a pharmaceutical company based in Harbin, China, operating within the Health Care sector. The company engages in the research, development, manufacture, wholesale, and retail of pharmaceutical products. It has 10,064 employees, with its headquarters located in Harbin, Heilongjiang Province. Founded through an IPO on June 29, 1993, the company is listed on the Shanghai Stock Exchange under the ticker 600664.SS. Harbin Pharmaceutical Group's primary business activities include innovative research and development in high-tech fields such as antibiotics, modern Chinese medicine, and biopharmaceuticals. The company operates across multiple sectors including antibiotics, over-the-counter drugs, health products, traditional and modern Chinese medicine, biomedicine, and pharmaceutical commerce. Its product portfolio features calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, alprostadil injection, pediatric paracetamol Huangnamin granules, lacidipine tablets, hydrochloric acid for injection Cefotiam, ibuprofen granules, and Xingaizhonggai high calcium tablets. The company's website is https://www.hayao.com/, though the source description provided is untrusted and should not be relied upon for factual accuracy. Harbin Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harbin Pharmaceutical Group Co stock

Earnings per Share (EPS) of Harbin Pharmaceutical Group Co is 0.14 CNY in 2025.

Earnings per Share (EPS) of Harbin Pharmaceutical Group Co changed from 0.24 CNY to 0.14 CNY, representing a -40.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Harbin Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Harbin Pharmaceutical Group Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Harbin Pharmaceutical Group Co